ELV · Elevance Health Inc
Price
Snapshot
50 fields · last close| Market Cap | $92.88B |
| P/E | 18.71 |
| Float | 216.3M |
| Beta | 0.64 |
| Volatility | 15.9% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 80.3 |
| Price | 426.37 |
| Change | −0.44% |
| Prev Close | 428.26 |
| Open | 433.34 |
| Day Low | 426.72 |
| Day High | 434.00 |
| Avg Vol | 1 |
| Avg $ Vol | $568.6M |
| 52W High | 436.24 |
| 52W Low | 274.84 |
| 52W Pos | 93.9% |
| From High | −2.26% |
| From Low | +55.13% |
| Max DD 1Y | −26.49% |
| Spread | 0.10% |
| Liquidity | Deep |
| SMA 20 | +5.36% |
| SMA 50 | +5.58% |
| SMA 200 | +15.49% |
| RSI (14) | 67.0 |
| Vol 30D | 24.6% |
| Vol 90D | 32.9% |
| 1Y Range | 275–436 |
| Daily bars | 537 |
| Perf Week | +3.77% |
| Perf Month | +3.38% |
| Perf Quarter | +12.04% |
| Perf Half Y | +34.10% |
| Perf Year | +23.00% |
| Perf YTD | +20.36% |
| Prev Day | −0.44% |
| Clavix | B+ |
| Debt / Eq | 0.73 |
| Curr Ratio | 1.54 |
| Int Cover | 5.1× |
| FCF Margin | 1.6% |
| Rev Growth | +12.5% |
| Profit | Profitable |
| Leverage | Moderate |
| Sector rank | 15 / 49 |
What ELV does
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.
The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits.
The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers.
In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services.
The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands.
The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022.
Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Clavix risk grade
regraded every trading dayELV grades B+, 80.3 of 100. Steadiest on Macro Resilience (71), most exposed on Price Stability (62, mixed). 4 of the 4 weighted dimensions sit above the Health Care median. Ranks 15 of 49 in Health Care by Clavix score.
How rough the ride is
| ELV | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.64 | 0.84 |
| Volatilityannualized | 15.9% | 20.9% |
| Max drawdown, past yearworst peak-to-trough fall | −26.5% | — |
| Typical daily movemedian absolute daily change | 1.14% | — |
| Days beyond ±3%of the last 252 sessions | 26 (10%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| ELV | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.64 | 0.84 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate 53% of 49 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| ELV | |
|---|---|
| 1 week | +3.8% |
| 1 month | +3.4% |
| Year to date | +20.4% |
| 1 year | +23.0% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| ELV | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 22 Jul |
| Average score0 most bearish, 100 most bullish | 53 |
| Bullish · bearisharticles above 60 · below 40 | 17 · 10 |
| Directionarticles whose tone is improving vs worsening | 17 ↑ 10 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.
Growth
| ELV | |
|---|---|
| Revenue growthyear over year | +12.5% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openGuggenheim raised its price target (the price the analyst thinks the stock will reach) on Elevance Health from $455 to $460 and kept a 'buy' rating in a research note issued Monday.
Elevance Health is up 19.2% over the past year, and the article asks whether that gain is justified by the company's earnings power given fresh Medicare product updates and planned 2027 Medicare Advantage offerings. The article body is short and does not describe a specific new development.
The article reports that a Long Island neurosurgery practice says it has fixed the deficiencies a judge identified when dismissing an earlier antitrust complaint against an Anthem unit over low reimbursement rates. No outcome of the amended complaint is mentioned.
Seven hospitals in six states have sued Anthem Blue Cross Blue Shield in a Georgia federal court, saying the insurer didn't pay claims at the rates it had agreed to and rejected claims for reasons not allowed by their contracts. The article provides no further detail, such as how much money is at stake or which hospitals are involved.
Elevance Health is cutting more than 300 jobs in Louisiana and Washington, D.C. as it reviews and exits parts of its Medicaid business. The company says it is assisting the affected workers. The article body is truncated, so additional details about timing and severance are not provided.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| HCA | HCA Healthcare Inc | B+ | $99.34B | 14.52 | 1.12 | Compare |
| CI | Cigna Group | A- | $79.88B | 12.45 | 0.25 | Compare |
| SYK | Stryker Corp | B | $113.0B | 30.31 | 0.79 | Compare |
| MCK | McKesson Corp | B+ | $117.2B | 25.51 | 0.30 | Compare |
| CVS | CVS Health Corp | A- | $118.1B | 24.16 | 0.58 | Compare |
| MDT | Medtronic PLC | A- | $121.2B | 23.16 | 0.59 | Compare |
| COR | Cencora Inc | B+ | $65.06B | 24.79 | 0.58 | Compare |
| BSX | Boston Scientific Corp | B | $64.33B | 17.51 | 0.59 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.